Seeking Alpha

Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting

NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, ...
Seeking Alpha

Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress

NEW YORK, Oct. 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is ...
Nasdaq

Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference

NEW YORK, Jan. 6, 2025 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, successfully sponsored and participated in the 4th ...
News Medical

Ablation Technology: Innovations and Industry Overview

Ablation therapy consists of a minimally invasive treatment, which can be used for treating cancer by destroying tumors and other abnormal tissues within the body. It uses either extremely high or low ...
Business Wire

Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...
Nasdaq

Catheter Precision, Inc. and Chelak iECG, Inc. Launch Joint Venture Kardionav for Advancements in Ventricular Tachycardia Ablation Technology

Catheter Precision, Inc. has formed a joint venture named Kardionav with Chelak iECG, Inc. to develop advanced technologies aimed at improving ablation procedures for ventricular tachycardia. Catheter ...
Business Wire

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...